Non-specific immunotherapy
Immunotherapy that is not cancer-specific is most effective when combined with other cancer treatments or after surgery to eliminate cancer cells. The most prevalent types of non-specific immunotherapy consist of:
Interleukins: Interleukins or IL-2 aid in the acceleration of immune system cell proliferation and division. IL-2 aids in the treatment of metastatic advanced melanoma and kidney cancer. You can use IL-2 alone or in conjunction with other cytokines to achieve more potent results.
Interferons are proteins that assist the immune system in alerting the body to the presence of pathogens. Interferons also inhibit the proliferation of cancer cells, with Alferon (2a), Intron A(2b), and Roferon A (2a) being the most prevalent.
